stoxline Quote Chart Rank Option Currency Glossary
  
Baird Medical Investment Holdings Limited (BDMD)
1.11  -0.07 (-5.93%)    08-27 16:00
Open: 1.14
High: 1.21
Volume: 31,410
  
Pre. Close: 1.18
Low: 1.11
Market Cap: 47(M)
Technical analysis
2026-08-27 4:42:43 PM
Short term     
Mid term     
Targets 6-month :  1.38 1-year :  1.53
Resists First :  1.18 Second :  1.3
Pivot price 1.16
Supports First :  0.99 Second :  0.82
MAs MA(5) :  1.16 MA(20) :  1.14
MA(100) :  1.36 MA(250) :  1.56
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  42.4 D(3) :  49
RSI RSI(14): 46.1
52-week High :  3.7 Low :  0.75
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ BDMD ] has closed above bottom band by 13.1%. Bollinger Bands are 52.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.21 - 1.22 1.22 - 1.22
Low: 1.09 - 1.1 1.1 - 1.11
Close: 1.1 - 1.11 1.11 - 1.12
Company Description

Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.

Headline News

Tue, 25 Aug 2026
Price to book forward of Baird Medical Investment Holdings Ltd – NASDAQ:BDMD - TradingView

Sat, 22 Aug 2026
BDMD | Baird Medical Investment Holdings Insider Trading - Quiver Quantitative

Thu, 20 Aug 2026
Baird Medical Investment Holdings Announces Product Registrations for BD-GT Microwave Ablation System and T-1610 Disposable Microwave Ablation Needle in Pakistan - marketscreener.com

Thu, 20 Aug 2026
Baird Medical Expands Global Microwave Ablation Footprint with Additional Product Registrations in Pakistan - GlobeNewswire

Mon, 17 Aug 2026
Baird Medical Investment (BDMD) Stock Analysis Report | Financials & Insights - Benzinga España

Fri, 31 Jul 2026
Baird Medical Investment (BDMD) stake structure detailed by ExcelFin SPAC - Stock Titan

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 32 (M)
Shares Float 12 (M)
Held by Insiders 64.8 (%)
Held by Institutions 0.7 (%)
Shares Short 20 (K)
Shares Short P.Month 33 (K)
Stock Financials
EPS -0.99
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.51
Profit Margin -121.1 %
Operating Margin -104.2 %
Return on Assets (ttm) -21.8 %
Return on Equity (ttm) -77.6 %
Qtrly Rev. Growth -39 %
Gross Profit (p.s.) 0.59
Sales Per Share 0.7
EBITDA (p.s.) -0.77
Qtrly Earnings Growth 0 %
Operating Cash Flow -1 (M)
Levered Free Cash Flow 8 (M)
Stock Valuations
PE Ratio -1.14
PEG Ratio 0
Price to Book value 0.73
Price to Sales 1.57
Price to Cash Flow -26.5
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android